Article ID Journal Published Year Pages File Type
2398667 Journal of Veterinary Behavior: Clinical Applications and Research 2015 6 Pages PDF
Abstract

Dysregulation of intracellular calcium is associated with increased age and may be linked to cognitive dysfunction syndrome in dogs. This study examined the effectiveness of apoaequorin, a calcium-buffering protein, in modifying cognitive decline in aged beagle dogs in 2 separate studies. In the first study, 23 aged beagle dogs were separated into groups treated with either a placebo, 2.5 mg, or 5 mg doses and were assessed on discrimination learning, attention, and visuospatial memory tasks. The apoaequorin-treated animals showed improved performance on both the discrimination learning and attention tasks but did not differ from the controls on the spatial memory task. In a second study, we compared 24 dogs treated with either a 5-mg or 10-mg dose of apoaequorin or with 1 mg/kg selegiline (Anipryl), an approved treatment for cognitive dysfunction. The group administered 10-mg apoaequorin showed superior performance to the animals administered selegiline on both tasks. These results suggest the calcium-binding protein apoaequorin may have beneficial effects in treating cognitive dysfunction in aged beagle dogs and that apoaequorin is at least as beneficial as selegiline.

Related Topics
Life Sciences Agricultural and Biological Sciences Animal Science and Zoology
Authors
, , , ,